Stocks · Health care · Biological Products, (No Diagnostic Substances)

NEUROCRINE BIOSCIENCES INC

NBIX Clue Score82
United States Fiscal year ends December CIK 0000914475 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Matt Abernethy
14 Sep 2026
Chief Financial Officer
Sold on a plan
2,311
$157.20
$363.28K
David W. Boyer
14 Sep 2026
Chief Corp. Affairs Officer
Sold on a plan
826
$157.45
$130.05K
Leslie Norwalk V
28 Jul 2026
Director
Sold on a plan
1,250
$182.01
$227.51K
Leslie Norwalk V
4 Jun 2026
Director
Sold on a plan
1,250
$168.06
$210.07K
David W. Boyer
26 May 2026
Chief Corp. Affairs Officer
Sold on a plan
3,888
$156.64
$609.02K
Leslie Norwalk V
12 May 2026
Director
Sold on a plan
3,810
$155.01
$590.60K
Leslie Norwalk V
16 Dec 2025
Director
Sold on a plan
1,190
$155.09
$184.56K

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 43
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 967,157
History held since 16 Jan 2007